FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:2089-2090 May 13, 2004 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by van Meurs, J. B.J. Related Article by McLean, R. R. PubMed Citation

Osteoporotic fractures are a major health problem in the industrialized nations, a problem that is likely to become even greater throughout the world as the population ages. One way to prevent osteoporotic fractures is to identify risk factors that can be readily reversed. Epidemiologic studies in the United States and Europe have identified many such factors. For example, supplementation with calcium and vitamin D has been shown to reduce the risk of fracture.

Two studies in this issue of the Journal introduce still another potentially reversible factor: increased circulating homocysteine levels.^1,2 There is ample evidence that high homocysteine levels are . . . [Full Text of this Article]

Source Information

From the University of Connecticut Center for Osteoporosis, University of Connecticut Health Center, Farmington.

Related Letters:

Homocysteine as a Predictive Factor for Hip Fracture in Older Persons
Auer J., Lamm G., Eber B., Bursztyn M., Pérez-Castrillón J. L., Arranz-Peña M. L., Luis D. D., Ellenberg S. S., Orloff D. G., Temple R. J., McLean R. R., Kiel D. P., van Meurs J. B.J., Pols H. A.P., Uitterlinden A. G., Raisz L. G.
Extract | Full Text | PDF  
N Engl J Med 2004; 351:1027-1030, Sep 2, 2004. Correspondence

This article has been cited by other articles:

• LeBoff, M. S., Narweker, R., LaCroix, A., Wu, L., Jackson, R., Lee, J., Bauer, D. C., Cauley, J., Kooperberg, C., Lewis, C., Thomas, A. M., Cummings, S. (2009). Homocysteine Levels and Risk of Hip Fracture in Postmenopausal Women. J. Clin. Endocrinol. Metab. 94: 1207-1213 [Abstract] [Full Text]  
• Wildschut, H. I.J., Peters, T.J., Weiner, C. P. (2006). Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis. Hum Reprod Update 12: 499-512 [Abstract] [Full Text]  
• Hamerman, D. (2005). Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM 98: 467-484 [Abstract] [Full Text]  
• Auer, J., Lamm, G., Eber, B., Bursztyn, M., Perez-Castrillon, J. L., Arranz-Pena, M. L., Luis, D. D., Ellenberg, S. S., Orloff, D. G., Temple, R. J., McLean, R. R., Kiel, D. P., van Meurs, J. B.J., Pols, H. A.P., Uitterlinden, A. G., Raisz, L. G. (2004). Homocysteine as a Predictive Factor for Hip Fracture in Older Persons. NEJM 351: 1027-1030 [Full Text]  
• Seeman, E., Strewler, G. J. (2004). Clinical and Basic Research Papers - May and June 2004 Selections. IBMS BoneKEy 1: 1-3 [Full Text]  
• (2004). An Association Between Homocysteine and Fractures. JWatch General 2004: 1-1 [Full Text]